4D Molecular Therapeutics, Inc.
EPS
| Fiscal Year | EPS | Cyclically Adjusted EPS |
|---|---|---|
| FY2021 | $-2.57 | $-8.48 |
| FY2022 | $-3.32 | $-7.25 |
| FY2023 | $-2.58 | $-6.33 |
| FY2024 | $-2.98 | $-5.77 |
| FY2025 | $-2.42 | $-5.29 |
EPS
| Fiscal Year | EPS | Cyclically Adjusted EPS |
|---|---|---|
| FY2021 | $-2.57 | $-8.48 |
| FY2022 | $-3.32 | $-7.25 |
| FY2023 | $-2.58 | $-6.33 |
| FY2024 | $-2.98 | $-5.77 |
| FY2025 | $-2.42 | $-5.29 |